These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 17393784)

  • 41. An analysis of the p63/alpha-methylacyl coenzyme A racemase immunohistochemical cocktail stain in prostate needle biopsy specimens and tissue microarrays.
    Sanderson SO; Sebo TJ; Murphy LM; Neumann R; Slezak J; Cheville JC
    Am J Clin Pathol; 2004 Feb; 121(2):220-5. PubMed ID: 14983935
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alpha-methylacyl coenzyme A racemase immunoreactivity in partial atrophy of the prostate.
    Adley BP; Yang XJ
    Am J Clin Pathol; 2006 Dec; 126(6):849-55. PubMed ID: 17074684
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Performance comparison of anti-p504s (SP116) Rabbit Monoclonal Primary Antibody vs. Monoclonal Rabbit Anti-Human AMACR clone 13H4 when duplexed with VENTANA Basal Cell Cocktail (34βE12+p63) as a diagnostic aid for prostatic adenocarcinoma using immunohistochemistry.
    Lindner V; Waydelich A; Chen CC; Jones C; Stratton SP
    Virchows Arch; 2021 Aug; 479(2):337-343. PubMed ID: 33811532
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Positive predictive value of high-grade prostatic intraepithelial neoplasia in initial core needle biopsies of prostate adenocarcinoma--a study with complete sampling of hemi-prostates with corresponding negative biopsy findings.
    Delatour NL; Mai KT
    Urology; 2008 Sep; 72(3):623-7. PubMed ID: 18279923
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prostatic basal cells in the peripheral and transitional zones: zonal variation in morphology and in immunophenotype.
    Garcia FU; Haber MM; Chen X
    Prostate; 2007 Nov; 67(15):1686-92. PubMed ID: 17879949
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prostate-specific antigen, high-molecular-weight cytokeratin (clone 34betaE12), and/or p63: an optimal immunohistochemical panel to distinguish poorly differentiated prostate adenocarcinoma from urothelial carcinoma.
    Kunju LP; Mehra R; Snyder M; Shah RB
    Am J Clin Pathol; 2006 May; 125(5):675-81. PubMed ID: 16707367
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Overexpression of ELAV-like protein HuR is associated with increased COX-2 expression in atrophy, high-grade prostatic intraepithelial neoplasia, and incidental prostate cancer in cystoprostatectomies.
    Barbisan F; Mazzucchelli R; Santinelli A; Lopez-Beltran A; Cheng L; Scarpelli M; Montorsi F; Montironi R
    Eur Urol; 2009 Jul; 56(1):105-12. PubMed ID: 18468781
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer.
    Shah RB; Zhou M; LeBlanc M; Snyder M; Rubin MA
    Am J Surg Pathol; 2002 Sep; 26(9):1161-8. PubMed ID: 12218572
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Application of combined immunohistochemical panel of AMACR(P504S)/p63 cocktail, cytokeratin 5 and D2-40 to atypical glands in prostatic needle biopsy.
    Kuroda N
    Malays J Pathol; 2014 Dec; 36(3):169-73. PubMed ID: 25500515
    [TBL] [Abstract][Full Text] [Related]  

  • 50. False positive labeling of prostate cancer with high molecular weight cytokeratin: p63 a more specific immunomarker for basal cells.
    Ali TZ; Epstein JI
    Am J Surg Pathol; 2008 Dec; 32(12):1890-5. PubMed ID: 18813120
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Basal cell hyperplasia (BCH) versus high grade prostatic intraepithelial neoplasia (HGPIN) in tiny prostatic needle biopsies: Unusual diagnostic dilemma.
    Yassin Fel-Z; Muhammad EM; Zaki M; Saleem MD; Mohammed RA
    J Egypt Natl Canc Inst; 2014 Mar; 26(1):15-22. PubMed ID: 24565678
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Expression of nucleostemin in prostate cancer tissues and its clinical significance].
    Liu RL; Xu Y; Zhang ZH; Wang M; Sun JT; Qi SY; Zhang Y; Li SZ
    Zhonghua Nan Ke Xue; 2008 May; 14(5):418-22. PubMed ID: 18572860
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic significance of alpha-methylacyl-coA racemase among men with high grade prostatic intraepithelial neoplasia in prostate biopsies.
    Stewart J; Fleshner N; Cole H; Toi A; Sweet J
    J Urol; 2008 May; 179(5):1751-5; discussion 1755. PubMed ID: 18343427
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression and diagnostic utility of alpha-methylacyl-CoA-racemase (P504S) in foamy gland and pseudohyperplastic prostate cancer.
    Zhou M; Jiang Z; Epstein JI
    Am J Surg Pathol; 2003 Jun; 27(6):772-8. PubMed ID: 12766580
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Monocarboxylate transporter 2 (MCT2) as putative biomarker in prostate cancer.
    Pértega-Gomes N; Vizcaíno JR; Gouveia C; Jerónimo C; Henrique RM; Lopes C; Baltazar F
    Prostate; 2013 May; 73(7):763-9. PubMed ID: 23192371
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discovery and clinical application of a novel prostate cancer marker: alpha-methylacyl CoA racemase (P504S).
    Jiang Z; Woda BA; Wu CL; Yang XJ
    Am J Clin Pathol; 2004 Aug; 122(2):275-89. PubMed ID: 15323145
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Value of the antibody cocktail anti p63 + anti p504s for the diagnosis of prostatic cancer].
    Molinié V; Hervé JM; Lebret T; Lugagne-Delpon PM; Saporta F; Yonneau L; Botto H; Baglin AC
    Ann Pathol; 2004 Feb; 24(1):6-16. PubMed ID: 15192532
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Assessment of P504S immunohistochemistry in diagnosis and differential diagnosis of prostatic adenocarcinoma].
    Chen GY; Liu LN; Zhou XG; Zhang CH; Huang SF
    Zhonghua Bing Li Xue Za Zhi; 2004 Oct; 33(5):419-23. PubMed ID: 15498210
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Achievements in morphological diagnosis of prostatic cancer: alpha-methylacyl-coenzyme-A-racemase--a new marker of malignant cell transformation].
    Pozharisskiĭ KM; Leenman EE; Arzumanov AA
    Arkh Patol; 2005; 67(5):15-9. PubMed ID: 16323473
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is there a role for prostate tumour overexpressed-1 in the diagnosis of HGPIN and of prostatic adenocarcinoma? A comparison with alpha-methylacyl CoA racemase.
    Scarpelli M; Mazzucchelli R; Barbisan F; Santinelli A; Lopez-Beltran A; Cheng L; Montironi R
    Int J Immunopathol Pharmacol; 2012; 25(1):67-74. PubMed ID: 22507319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.